p.V450M | TCGA-85-6560 | LUSC | TCGA | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.2222 |
p.V450M | DO48228 | ESCA | ICGC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.2222 |
p.V450M | DO26752 | LUSC | ICGC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.2222 |
p.V464I | TCGA-AY-6197 | COAD | TCGA | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.1944 |
p.V464I | DO9956 | COAD | ICGC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.1944 |
p.V464I | SIDM00454 | Rhabdomyosarcoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.1944 |
p.E446K | TCGA-BG-A222 | UCEC | TCGA | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.1111 |
p.E446K | DO42977 | UCEC | ICGC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.1111 |
p.R444L | TCGA-EE-A2ME | SKCM | TCGA | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.0556 |
p.R444L | TCGA-GN-A262 | SKCM | TCGA | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.0556 |
p.R444L | DO37515 | SKCM | ICGC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.0556 |
p.R444L | DO38011 | SKCM | ICGC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.0556 |
p.S449R | TCGA-G7-A8LD | KIRP | TCGA | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation blocking phosphorylation signal | 0.6389 |
p.S449R | DO49761 | KIRP | ICGC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation blocking phosphorylation signal | 0.6389 |
p.S449R | DO229031 | LICA | ICGC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation blocking phosphorylation signal | 0.6389 |
p.S449R | DO229041 | LICA | ICGC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation blocking phosphorylation signal | 0.6389 |
p.P347Q | DO229036 | LICA | ICGC | IRVYPE | LIG_APCC_ABBA_1 | 343:348 | Mutation altering degron motif | 0.5924 |
p.V464F | DO229221 | THCA | ICGC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.1944 |
p.R344H | SIDM01048 | Plasma Cell Myeloma | GDSC | IRVYPE | LIG_APCC_ABBA_1 | 343:348 | Mutation altering degron motif | 0.7133 |
p.R344H | EJM | haematopoietic and lymphoid tissue | COSMIC | IRVYPE | LIG_APCC_ABBA_1 | 343:348 | Mutation altering degron motif | 0.7133 |
p.D459N | SIDM00926 | Non-Small Cell Lung Carcinoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM00513 | Non-Small Cell Lung Carcinoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM00654 | Small Cell Lung Carcinoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM00286 | Neuroblastoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM01039 | Other Solid Cancers | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM00522 | Small Cell Lung Carcinoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM00971 | Breast Carcinoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM00254 | Neuroblastoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM00896 | B-Cell Non-Hodgkin's Lymphoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM00097 | Breast Carcinoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM01159 | Other Sarcomas | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM00864 | Cervical Carcinoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM00225 | Melanoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.D459N | SIDM01502 | Endometrial Carcinoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation altering degron motif | 0.6932 |
p.E445K | SIDM00213 | Thyroid Gland Carcinoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.0833 |
p.E445K | SIDM00228 | Thyroid Gland Carcinoma | GDSC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.0833 |
p.E445K | ACH-000249 | Colon/Colorectal Cancer | CCLE | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.0833 |
p.E445K | ACH-000897 | Thyroid Cancer | CCLE | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.0833 |
p.E445K | ACH-000903 | Thyroid Cancer | CCLE | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.0833 |
p.E445K | FTC-133 | thyroid | COSMIC | FYVFSD | LIG_APCC_ABBA_1 | 454:459 | Mutation rewiring degron network | 0.0833 |
p.Q352P | ACH-001624 | Brain Cancer | CCLE | IRVYPE | LIG_APCC_ABBA_1 | 343:348 | Mutation rewiring degron network | 0.2222 |
p.N339I | KYSE-70 | oesophagus | COSMIC | IRVYPE | LIG_APCC_ABBA_1 | 343:348 | Mutation rewiring degron network | 0.2222 |